Hubungan Ekspresi Matriks Metalloproteinase-9 (MMP-9) Dengan Derajat Destruksi Tulang Pada Penderita OMSK Tipe Bahaya di RSUP Haji Adam Malik Medan

DAFTAR PUSTAKA
Aboet A, 2008, Radang Telinga Tengah Menahun, Pidato Pengukuhan
Jabatan Guru Besar Tetap Bidang Ilmu Kesehatan Telinga Hidung
Tenggorok Bedah Kepala Leher, Universitas Sumatera Utara, USU
e-Repository, Medan.
Ahmed M, Mohammed S, 2011. Metalloproteinases 2 and 9 in situ mRNA
expression in colorectal tumors from Iraqi patients. Indian Journal
Pathology & Microbiology, 54(1); p. 7-14.
Akyıldız I, Take G, Uygur K, Kızıl Y, Aydil U, 2013. Bacterial Biofilm
Formation in the Middle-Ear Mucosa of Chronic Otitis Media Patients.
Indian J Otolaryngol Head Neck Surg, 65 (Suppl 3):p.557–61.
Albino A, Kimmelman C, Parisier S, 1998. Cholesteatoma: a molecular
and cellular puzzle. Am J Otol.19(1):p.7-19.
Alves AL, Ribeiro F, 2004. The role of cytokines in acquired middle ear
cholesteatoma: literature review. Rev Bras Otorrinolaringol. V.70,
n.6, p.813-8.
Alves A, Barbosa S, Pereira, Carvalho M, Fregnani J, Ribeiro F, 2012.
EGFR expression in acquired middle ear cholesteatoma in children
and adults. Eur J Pediatr. 171:p.307–10.
Amalinei C, Caruntu I, Balan R, 2007. Biology of metalloproteinases.
Romanian Journal of Morphology and Embryology, 48(4):p.323–34.

Aquino, Filho, NAC & Aquino, 2011. Epidemiology of Middle Ear and
Mastoid Cholesteatomas, Study of 1146 cases, Brazillian Journal of
Otorhinolaryngology, vol.77,no3, May-June, p.1-11.
Aruan SY, 2014. Tesis Spesialis, Hubungan ekspresi tumor necrosis factor
alpha (TNF-α) dengan derajat destruksi tulang akibat kolesteatoma
pada penderita otitis media supuratif kronis tipe bahaya.
Arts A & Adams M, 2014. Intratemporal and Intracranial Complications of
Otitis Media, in Bailey Otolaryngology Head & Neck Surgery, 4th
Edition, Lippincott William& Wilkins, p.2399-409.

54
Universitas Sumatera Utara

55

Baig M, Ajmal M, Saeed I, Fatima S, 2011, Prevalence of Cholesteatoma
and its Complication in Patients of Chronic Suppurative Otitis Media,
Journal of Rawalpindi Medical College (JRMC), vol 15, p.16-17.
Bode W, Catalan C, Tschesche H, Grms F, Nagase H, Maskos K, 1999.
Structural properties of matrix metalloproteinases. CMLS Cellular

and Molecular Life Sciences. 55, p.639-52.
Browning G, Merchant S, Kelly, G, Swan I, Canter, R, McKerrow W,
2008.`Chronic Otitis Media`, in: Scott-Brown`s Otorhinolaryngology,
Head and Neck Surgery, Edward Arnold Ltd, London, p.3395-442.
Chen P, Shih Y, Huang H, Cheng H, 2011. Diosgenin, a Steroidal
Saponin, Inhibits Migration and Invasion of Human Prostate Cancer
PC-3 Cells by Reducing Matrix Metalloproteinases Expression.
PlosOne 6(5) :p.1-9.
Chole R, Nason R, 2009, Chronic Otitis Media and Cholesteatoma, in
Ballenger’s Otorhinolaryngoligy Head and Neck Surgery, BC Becker
Inc, Shelton Connecticut, USA, p.217-38.
Chole, RA & Sudhoff, HH 2005, `Chronic otitis media, mastoiditis, and
petrositis`, dalam CW Cummings et al. (eds), Otolaryngology: Head
& Neck Surgery, Mosby, Inc, Philadelphia.
Deb T, Ray D, 2012. A Study of Bacteriological Profile of Chronic
Suppurative

Otitis

Media

in

Agartala.

Indian

Journal

of

Otolaryngology Head and Neck Surg. 64(4); p. 326-9.
Decock J, Hendrickx W, Vanleeuw U, Belle V, Huffel S, Christiaens, M,
Ye S, Paridaens R, 2008. Plasma MMP I and MMP 8 expression in
breast cancer: Protective role of MMP8 against lymph node
metastasis. BMC Cancer, 8:77, p.1-8.
Dhingra PL, 2014, Cholesteatoma and Chronic Suppurative Otitis Media,
in Disease of Ear Nose and Throat, sixth Edition, Elsevier, p.66-73.
Djaafar ZA, Helmi, Restuti R, 2007. Kelainan Telinga Tengah, Dalam:
Soepardi EA. Buku Ajar THT-KL. Edisi 6. Jakarta. Balai Penerbit

FKUI; p.66-77.

Universitas Sumatera Utara

56

Edward Y, Mulyani S, Triansyah I, 2013. Profil Pasien OMSK di Bagian
THT-KL RSUP DR. M. Djamil Padang Periode 1 Januari 2010-31
Desember 2012. Kumpulan Naskah Ilmiah KONAS XVI PERHATI-KL
Medan, p.190-7.
Frickmann H, Zautner A, 2012, Cholesteatoma – A Potential Consequence
of Chronic Middle Ear Inflammation, Review Article, Germany, p.1-8.
Fukuda T, Takahashi H, Koji T, 2011. Animal Models of Middle Ear
Cholesteatoma. Review Article, Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology,p.1-11.
Gacek, R 2009, `Anatomy of the auditory and vestibular system`, dalam
JB Snow & PA Wackyym (eds), Ballenger’s Otorhinolaryngology
Head And Neck Surgery, BC Decker inc, Connecticut.
Gailardin, L. Lescana, S., Moriniere, J., Cottier, A., Robier, A. 2012.
Residual cholesteatoma : Prevalence and Location. Follow up

Strategy in Adults. Otolaryngology Pol. Vol 12. p.132-6
Ghanie A, 2013. Otitis Media Supuratif Kronik Dengan Komplikasi
Intrakranial di RSUP Dr. Mohammad Hoesin. Kumpulan Naskah
Ilmiah KONAS XVI PERHATI-KL Medan, p.144-51.
Gulya A, Anatomy of the ear and temporal bone. In: GlasscockShambaugh Surgery of the Ear. Fifth edition, BC Decker Inc, Spain:
p.35-57.
Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura Y,
Kojima T, Iwata N, Ahmed AR, Dahy K, Kondo N, Suzuki K, 2016.
Pathogenesis and Bone Resorption in Acquired Cholesteatoma:
Current

Knowledge

and

Future

Prospectives,

Clinical

and

Experimental Otolaryngology, Korean Society of OtolaryngologyHead and Neck Surgery, p.1-11.
Hardjolukito & Endang, SR 2005, ′The 8th Course and Workshop, Basic
Science In Oncology′, Modul A, Putaran Ke-3, Jakarta.
Hashimoto-Ikehara, M, Mishiro, Y, Kitahara,T & Sakagami, M 2011,`The
10-Year Disease-Free Rate of Attic Cholesteatoma Based on a New
Staging System`, Int. Adv. Otol, vol. 7, no.3, Hal. 289-92.

Universitas Sumatera Utara

57

Helmi. 2005, `Otitis media supuratif kronis`, dalam Otitis Media Supuratif
Kronis:

Pengetahuan

Dasar,

Terapi

Medik,

Mastoidektomi,

Timpanoplasti. Balai Penerbit FK-UI, Jakarta.
Islam, R,

Taous, A,

Hossain, M, Ekramuddaula, Islam M, 2010,

′Comparative Study of Tubotympanic and Atticoantral Variety of
Chronic

Suppurative

Otitis

Media′,

Bangladesh

Journal

Otolaryngology, Vol 16, no. 2, p.113-9.
Jesionek D, Szyman´ski M, Kurzepa J, GołEbek W, Stryjecka-Zimmer M,
2008. Gelatinolytic Activity of Matrix Metalloproteinases 2 and 9 in
Middle Ear Cholesteatoma. Journal of Otolaryngology-Head & Neck
Surgery, Vol 37, No 4; p.1-6.
Juhn S, Jung M, Hoffman M, Drew B, Preciado D, Sausen N, Timothy,
Jung K, Kim B, Park S, Lin J, Ondrey F, Mains D, Huang T, 2008,
The Role of Inflammatory Mediators in the Pathogenesis of Otitis
Media and Sequelae, Clinical and Experimental Otorhinolaryngology,
Vol 1, No.3, USA, p.117-38.
Jung JY, Chole R, 2002. Bone resorption in Chronic Otitis Media: The role
of Osteoclast. Journal for Oto - Rhino - Laryngology and Its Related
Specialties; 64, 2; p.95-107.

Juha´sz A, Sziklai I, Ra´kosy Z, Ecsedi S, A´ da´ny R, Bala´zs M, 2009.
Elevated Level of Tenascin and Matrix Metalloproteinase 9
Correlates With the Bone Destruction Capacity of Cholesteatomas.
Otology & Neurotology 30:p.559-65
Karnik P, Matta I, Chhapola I, 2011; Etiopathology of acquired
cholesteatoma, Review Article, Department of ENT, Mumbai Port
Trust Hospital, Wadala (E), Mumbai, Maharashtra, India, Vol 17,
Issue 2, p.54-57.
Khasigov P, Podobed O, Ktzoeva S, Gatagonova T, Gracher S, Shiskin S,
Berezov T, 2001. Matrix Metalloproteinases of Normal Human
Tissue. Biochemistry (Moscow) Vol.6 No.2. p.130-40.
Kuczkowski

J,

Sakowicz-Burkiewicz,

M,

Iżycka-Świeszewska

E,

Mikaszewski B, Pawełczyk T, 2011. Expression of tumor necrosis

Universitas Sumatera Utara

58

factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic
otitis media with bone osteolysis. ORL J Otorhinolaryngol Relat
Spec, vol. 73, no.2, p.93-9
Kumar S, Aqil S, Dahar A, 2011. Clinical Markers of Cholesteatoma,
Journal of Otorhinolaryngology’, vol.09, no.03, pp.138-40.
Lee KJ, 2008, Infections of the Ear, in Essential Otolaryngology Head &
Neck Surgery, Ninth Edition, The McGraw-Hill, USA, p.304-40.
Maru N, Pop FL, 2006, Morphological Considerations about Middle Ear
Cholesteatoma, Original Article, Romanian Journal of Morphology
and Embriology, 47(1), Romania, p.73-77.
Maniu A, Harabagiu O, Schrepler M, Catana A, Fanuta B, Mogianta C,

2014, Molecular Biology Of Cholesteatoma, Romanian Journal of
Morphology and Embriology, 55(1), Romania, p.7-13.
Memon A, Matiullah S, Ahmed Z, Marfani M, 2008, Frequency of Un-Safe
Chronic Suppurative Otitis Media in Patients with Discharging Ear,
Original Article, JLUMHS, p.102-5.
Menner A, 2003. The middle ear, in A Pocket Guide to the Ear. Thieme
Stuttgart, New York; p.15-21.
Meyer T, Strunk C, Lambert P, 2014, Cholesteatoma, in Bailey
Otolaryngology Head & Neck Surgery, 4th Edition, Lippincott William&
Wilkins, p.2433-46.
Morales D, Penido N, da Silva I, Stávale J, Guilherme A, Fukuda Y, 2007.
Matrix Metalloproteinase 2: an important genetic marker for
cholesteatomas. Rev Bras Otorrinolaringol ;73(1):55-61.
Ningsih M, 2015. Tesis spesialis. Hubungan Ekspresi Interleukin-1 dengan
derajat destruksi tulang akibat kolesteatoma pada penderita Otitis
media supuratif kronik tipe bahaya.
Novita CE, 2014. Hubungan ekspresi Ki-67 dengan derajat destruksi
tulang akibat kolesteatoma pada penderita otitis media supuratif
kronis tipe bahaya.
Nora B, 2011. Tesis, Gambaran Otitis Media Supurati Kronis di RSUP H.
Adam Malik Medan Tahun 2008.

Universitas Sumatera Utara

59

Nukarinen E, Lindström O, Kuuliala K, Kylänpää L, Pettilä V, Puolakkainen
P, Kuuliala A, Hämäläinen M, Moilanen E, Repo H, Hästbacka J,
2016. Association of Matrix Metalloproteinases -7,-8 and -9 and
TIMP -1 with Disease Severity in Acute Pancreatitis. A Cohort Study,
PLOS ONE | DOI:10.1371/journal.pone.0161480. p.1-11.
Olszewska E, Matulka M, Mroczko B, Pryczynicz A, Kemona A,
zmitkowski M, Mierzwinski J Pietrewicz T, 2016. Diagnostic value of
matrix

metalloproteinase

9

and

tissue

inhibitor

of

matrix

metalloproteinases 1 in cholesteatoma. Histol Histopathol 31: 307-15
Persaud R, Hajioff D, 2007. Evidence –based Review of Aethiopathogenic
theories

of Congenital and Acquired Cholesteatoma. Journal of

Laryngology & Otology. p.1013-9.
Poe D, Gopen Q, 2009, Eusthacian Tube Dysfunction, in Ballenger’s
Otorhinolaryngology Head and neck Surgery, BC Decker Inc,
Connecticut, p.201-8.
Popescu C, Ionita E, Mogoantă CA, Simionescu C, Pătru E, 2009. Clinical
and histopathological aspects in otomastoiditis. Romanian Journal of
Morphology and Embryology, 50(3):453–60.
Rezende CE, doSouto R, Rapoport P, de Campos L, Generato M,
2012.Cholesteatoma gene expression of matrix metalloproteinases
and their inhibitors by RT-PCR.Braz J Otorhinolaryngol;78(3);p.11621.
Rout M, Mohanty D, Vijaylaxmi Y, Kamalesh B, Chakradhar M, 2012;
Prevalence of cholesteatoma in CSOM with central perforation,
Original Article, Indian Journal of Otology, 18(1), p.7-10.
Schmidt M, Grunsfelder P, Hoppe F, 2001. Up-regulation of matrix
metalloprotease-9 in middle ear cholesteatoma–correlations with
growth factor expression in vivo?, Eur Arch Otorhinolaryngol (2001)
258 :p.472–76.
Schonermark M, Mester B, Kempf H, Blaser J, Tschesche H, Lenarz T,
1996. Expression of Matrix-Metalloproteinases and their Inhibitors in
Human Cholesteatomas. Acta Otolaryngol (Stockh), 16: p.451-6

Universitas Sumatera Utara

60

Siregar, DR 2013, Tesis FK USU, ′Profil Penderita Otitis Media Supuratif
Kronis (OMSK) Tipe Bahaya di RSUP. H. Adam Malik Medan Tahun
2006 –2010.
Son E, Young D, Quinn F, Quinn M, 2013. Cholesteatoma, an Overview.
Grand Rounds Presentation, Department of Otolaryngology – Head
and Neck Surgery The University of Texas Medical Branch (UTMB)
Health;1-9.
Srivastava A, Singh RK, Varshney S, Gupta P, Bist SS, Bhagat S, Gupta
N. 2010. Microbiological Evaluation of an active Tubotympanic Type of
Chronic Suppurative Otitis Media. Nepalese Journal of ENT Head &
Neck Surgery. Vol. 1(2).
Stark AM, Anuszkiewicz B, Mentlein R, Yoneda T, H Mehdorn HM, HeldFeindt J, 2007 Differential expression of matrix metalloproteinases
in brain- and bone-seeking clones of metastatic MDA-MB-231breast
cancer cells, J Neurooncol, 81:p.39–48.
Sudhoff H, Dazert S, Gonzales A, Borkowski G, Park S, Baird A, Hildmann
H, Ryan A, 2000, Angiogenesis and Angiogenic Growth Factors in
Middle Ear Cholesteatoma, The American Journal of Otology,
California, U.S.A. p.793–98.
Sudiana, I & Ketut 2005, ′Teknologi Ilmu Jaringan dan Imunohistokimia′,
Sagung Seto, Jakarta.
Suryanti D, Rukmini, 2003. Abstrak, ′Otitis media supuratif kronik di Poli
THT RS Soetomo Surabaya tahun 2002′, dalam Kongres Nasional
XIII PERHATI-KL, Bali.
Thornton D, Martin T, Amin P, Haque S, Wilson S, Smith M, 2011. Chronic
suppurative otitis media in Nepal: ethnicity does not determine
wether disease is associated with cholesteatoma or not. The Journal
of Laryngology & Otology 125,p. 22-6.
Usmanova ZA, 2015. Relationship between the Levels of MMP-9, TIMP-1,
and

Zinc

in

Biological

Samples

of

Patients

with

Carotid

Atherosclerosis. International Journal of Biomedicine 5(2) p.60-4.

Universitas Sumatera Utara

61

World Health Organization 2004, Chronic Suppurative Otitis Media.
Burden of Illness and Management Options Geneva, WHO,
Switzerland.
Wright T, Valentine P, 2008, The Anatomy and Embriology of the External
and Middle Ear, in Scott-Brown’s Otorhinolaryngology Head and
Neck Surgery, Volume 3, p.3105-25.
Vasala K, 2008. Matrix metalloproteinase MMP-2 and MMP-9 and their
Inhibitors

TIMP-1

and

TIMP-2

In

bladder

carcinoma.

Acta

Universitatis Ouluensis, University press : 22-53.
Verhoeff M, Van der veen E, Rovers M, Sanders E, Schilder A, 2006.
Chronic Suppuratice Otitis Media; A Review, International Journal of
Pediatric Otorhinolaryngology, 70; p.1-12.
Verma R, Hansch C, 2007. Matrix metalloproteinases (MMPs): Chemical–
biological functions and (Q)SARs. Bioorganic & Medicinal Chemistry
15 (2007), Elsevier, p.2223–68.
Yarisman L, 2015. Tesis Spesialis, Hubungan Ekspresi RANKL Terhadap
deraJat Destruksi Tulang Pada Penderita OMSK tipe Bahaya di
RSUP H. Adam malik Medan.
Yates, PD & Anari, S 2008, `Otitis media`, dalam AK Lalwani (ed), Current
Otolaryngology, The McGraw-Hill Companies, New York.
Yoshizaki T, Sato H, Furukawa M, Pagano J, 1998. The expression of
matrix metalloproteinase 9 is enhanced by Epstein–Barr virus latent
membrane protein 1. Proc Natl Acad Sci USA, 95 : 3621-6.
Yousuf M, Majumder K, Kamal A, Shumon A, Zaman Y, 2011; Clinical
Study on Chronic Suppurative Otitis Media with Cholesteatoma,
Bangladesh Journal of Otorhinolaryngol, Vol 17, p.42-47.
Zarandy M, Rutka J, 2010. Cholesteatoma and its complications, in:
Diseases of the Inner Ear. Springer-Verlag Berlin Heidelberg; p.9-17.
Zhu W, Xie Y, Wang P, 2001. Expression of matrix metalloproteinase 2,9
in cholesteatoma and middle ear cancer. Zhongua Er Bi Yan Hou Ke
Za Zhi xue hui Beijing, 36(2); p.11-9.

Universitas Sumatera Utara